ZYNSGRI

Serial Number 90627262
606

Registration Progress

Application Filed
Apr 6, 2021
Under Examination
Feb 1, 2022
Approved for Publication
Dec 7, 2021
Published for Opposition
Dec 7, 2021
Registered

Trademark Image

ZYNSGRI

Basic Information

Serial Number
90627262
Filing Date
April 6, 2021
Published for Opposition
December 7, 2021
Abandonment Date
September 4, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 4, 2023
Classes
005

Rights Holder

Travere Therapeutics, Inc.

03
Address
Suite 300
3611 Valley Centre Drive
San Diego, CA 92130

Ownership History

Travere Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Travere Therapeutics, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Sep 5, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 4, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 3, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 1, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 1, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 29, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 27, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 27, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 27, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 1, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 7, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 7, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 29, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 9, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005